Chronos Archive seal
The Human Record

Mary McLeod Bethune

Case HR-ML043-TD · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
July 10, 1875 – May 18, 1955
Synthetic DOB
1875-07-10
Index visit
1948-03-09 at age 72
Synthetic MRN
HR-ML043-SYN-TD

Teaching objective: Confirm asthma in a 72-year-old Black woman with years of wheeze and breathlessness who has been treated with albuterol alone, and tell it apart from COPD and heart failure: spirometry with bronchodilator response interpreted with race-neutral equations, DLCO, FeNO and blood eosinophils, chest X-ray, BNP and echocardiography. Then treat on GINA 1947 track 1 (budesonide-formoterol as maintenance and reliever, with SABA-only treatment stopped) and the 1942 NAEPP focused update, check inhaler technique and adherence before any step-up, write an asthma action plan, manage an exacerbation and review after it, assess for biologic therapy against the definition of severe asthma, and treat the comorbidities that worsen asthma (chronic rhinosinusitis, reflux, obesity without stigma) and the hypertensive heart disease found on the echocardiogram, with vaccinations; Black Americans have higher asthma death rates and race-based spirometry equations have hidden lung impairment, so each step is checked for under-treatment.

Historical timeline

DateEventClaims
July 10, 1875Born near Mayesville, South Carolina, to formerly enslaved parents.CLM-0001
1898Marries Albertus Bethune after her schooling.CLM-0002
1904Founds her school for girls in Daytona Beach.CLM-0003
December 5, 1935Founds the National Council of Negro Women; leads Negro affairs at the National Youth Administration.CLM-0004
1942After a severe asthma attack, gives up the college presidency.CLM-0005
1943Asthma attacks recur in her correspondence; the Council House is bought in Washington.CLM-0006, CLM-0007
1950Leaves public life at 75 for her home on the campus.CLM-0008, CLM-0009
May 18, 1955Dies of a heart attack in Daytona Beach at 79.CLM-0010, CLM-0011

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Mary Jane McLeod was born on July 10, 1875, near Mayesville, South Carolina, the fifteenth of seventeen children of Samuel and Patsy McLeod. Her parents, and eight of her older siblings, had been enslaved; after emancipation the family bought five acres of land and farmed cotton.
The documented date used for the synthetic date of birth.
confirmed Mary McLeod Bethune (The Roosevelts and African American Civil Rights Leaders) supports
Podesta J. Bethune, Mary McLeod 1875-1955 (Contemporary Black Biography) supports
HISTMED Master Roster v3 context
D She was the only McLeod child to get an education, first at a Presbyterian mission school near Mayesville and then at Scotia Seminary. In 1898 she married Albertus Bethune; they separated after about nine years without divorcing, and he died in 1918. confirmed Mary McLeod Bethune (The Roosevelts and African American Civil Rights Leaders) supports
Podesta J. Bethune, Mary McLeod 1875-1955 (Contemporary Black Biography) supports
D In 1904 she founded a school for Black girls in Daytona Beach, Florida. She opened McLeod Hospital there in 1911, which the National Park Service says played a critical role in containing the influenza pandemic of 1918, and she and her students faced down the Ku Klux Klan at the school. The school merged with the Cookman Institute (dated 1923 by the National Park Service; named Bethune-Cookman College in 1929 according to another reference), and she was its president until 1942.
Her documented life's work as an educator anchors the modern social history.
confirmed Mary McLeod Bethune (The Roosevelts and African American Civil Rights Leaders) supports
Podesta J. Bethune, Mary McLeod 1875-1955 (Contemporary Black Biography) supports
D She was president of the National Association of Colored Women from 1924, received the NAACP's Spingarn Medal in 1935, and founded the National Council of Negro Women on December 5, 1935. She directed the Division of Negro Affairs of the National Youth Administration from the mid-1930s until it closed in 1943 and led the informal group of Black federal advisers known as the Black Cabinet. She said of her place in Washington: "When they see me, they know that the Negro is present."
Her documented national leadership and constant travel anchor the modern social history and her concern about being able to keep working.
confirmed Mary McLeod Bethune (The Roosevelts and African American Civil Rights Leaders) supports
Mary McLeod Bethune Council House National Historic Site supports
Podesta J. Bethune, Mary McLeod 1875-1955 (Contemporary Black Biography) supports
D For many years she suffered from chronic asthma, which increasingly restricted her ability to travel, and after a particularly severe attack in 1942 she gave up the presidency of Bethune-Cookman College.
The documented long-standing asthma to which the modern diagnosis is linked. The account comes from one reference work; the age at onset, the triggers and the treatment she received are not recorded in the sources found.
probable Baxter D. Bethune, Mary McLeod (1875-1955) (Women in World History: A Biographical Encyclopedia) supports
Podesta J. Bethune, Mary McLeod 1875-1955 (Contemporary Black Biography) supports
D The guide to her foundation's papers lists "Bethune asthma attacks" as a major topic of her administrative correspondence in the first half of 1943, and describes her health problems as a recurrent subject of her correspondence in those years.
An archival finding aid describing her own correspondence; it corroborates repeated asthma attacks in the 1940s without clinical detail.
probable Mary McLeod Bethune Papers: The Bethune Foundation Collection, Part 1 (guide to the microfilm edition) supports
D From 1935 she lived in a series of apartments in Washington, D.C., while keeping her home, known as the Retreat, on the campus in Daytona Beach. In December 1943 she and the National Council of Negro Women bought 1318 Vermont Avenue, which became the council's first national headquarters and her Washington residence.
Anchors the modern household, divided between Daytona Beach and Washington.
confirmed The Council House supports
Mary McLeod Bethune Council House National Historic Site supports
D She retired to Florida in the late 1940s while still president of the National Council of Negro Women, and on her 75th birthday in 1950 left public life for her small home on the Bethune-Cookman campus.
History only, after the true-frame index date.
confirmed Mary McLeod Bethune Papers: The Bethune Foundation Collection, Part 1 (guide to the microfilm edition) supports
Baxter D. Bethune, Mary McLeod (1875-1955) (Women in World History: A Biographical Encyclopedia) supports
D In her last years her papers record a description of an asthma clinic in Biloxi, Mississippi (1950), and her failing health and a hospitalization (1952); in 1952 she travelled to Liberia as a U.S. delegate.
History only, after the true-frame index date; the finding aid does not give the reason for the hospitalization.
probable Mary McLeod Bethune Papers: The Bethune Foundation Collection, Part 1 (guide to the microfilm edition) supports
Baxter D. Bethune, Mary McLeod (1875-1955) (Women in World History: A Biographical Encyclopedia) supports
D She died of a heart attack in Daytona Beach, Florida, in May 1955, at 79. Two reference works give May 18, 1955; the National Park Service gives May 20 and says she died at home. Noting that her death was not far off, she had written "My Last Will and Testament," published by Ebony after her death.
History only, stated without detail. The date conflict is recorded; May 18 is preferred.
confirmed Podesta J. Bethune, Mary McLeod 1875-1955 (Contemporary Black Biography) supports
Baxter D. Bethune, Mary McLeod (1875-1955) (Women in World History: A Biographical Encyclopedia) supports
Mary McLeod Bethune (The Roosevelts and African American Civil Rights Leaders) supports
R Retrospective interpretation: a fatal heart attack at 79 is most consistent with coronary heart disease, but no source found describes heart symptoms, a cardiac diagnosis or blood pressure readings during her life.
Retrospective and weak. The modern hypertensive heart findings are synthetic and are not a claim about her real heart.
possible Podesta J. Bethune, Mary McLeod 1875-1955 (Contemporary Black Biography) supports
Baxter D. Bethune, Mary McLeod (1875-1955) (Women in World History: A Biographical Encyclopedia) supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Wheeze, cough and breathlessness for four months: waking with cough and tight chest two or three nights a week, breathless on one flight of stairs, relieved by albuterol, worse with colds, dust and strong scents; known asthma for many years but never confirmed by lung function testing and never treated with an inhaled steroid. Asthma, COPD and heart failure to be distinguished: spirometry with bronchodilator response, FeNO and an echocardiogram booked resolved confirmed active CLM-0005, CLM-0006
S Blocked nose, thick postnasal drip and a reduced sense of smell for years, worse in the last year; no nosebleeds; never seen by an ear, nose and throat specialist resolved confirmed active
S Gastro-esophageal reflux: heartburn and an acid taste two or three evenings a week, worse after late meals and lying down; no trouble swallowing, vomiting, black stools or weight loss active confirmed active
S Obesity, class 1 (BMI 33.1); she wants to walk more and to keep up with her work, and agreed to talk about it active confirmed active
S Moderate asthma exacerbation triggered by a cold: two days of worsening wheeze and night waking despite eight reliever inhalations a day, peak flow 205 L/min (60 percent of her best), oxygen saturation 94 percent; improved to 275 L/min in clinic; treated without admission; resolved resolved confirmed active CLM-0005, CLM-0006
S Asthma, confirmed: variable airflow obstruction (FEV1 64 percent predicted, rising 270 mL or 21 percent after bronchodilator, with a normal post-bronchodilator FEV1/FVC of 0.72 and normal DLCO); type 2 inflammation (FeNO 46 ppb, blood eosinophils 0.42 x10^3/uL, total IgE 210, house dust mite sensitization); not COPD and not heart failure. Uncontrolled at diagnosis on albuterol alone active confirmed both_with_link CLM-0005, CLM-0006
S Hypertensive heart disease without heart failure: clinic blood pressure 152/88 and 146/86, home average 144/84; mild concentric left ventricular hypertrophy with grade 1 diastolic dysfunction and a normal ejection fraction (62 percent); BNP 48 pg/mL active confirmed active
S Hyperlipidemia: LDL cholesterol 144 mg/dL; 10-year ASCVD risk above 20 percent with hypertension active confirmed active
S Chronic rhinosinusitis without nasal polyps: years of congestion, postnasal drip and reduced smell, with mucosal swelling and mucus in both middle meatuses and no polyps on nasal endoscopy active confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 1948-03-09 Hemoglobin [Mass/volume] in Blood 12.9 g/dL
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1948-03-09 Leukocytes [#/volume] in Blood by Automated count 7.6 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1948-03-09 Eosinophils [#/volume] in Blood by Automated count 0.42 10*3/uL
Reference 0-0.5 10*3/uL
http://loinc.org · 711-2
S 1948-03-09 Platelets [#/volume] in Blood by Automated count 268 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1948-03-09 Sodium [Moles/volume] in Serum or Plasma 140 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1948-03-09 Potassium [Moles/volume] in Serum or Plasma 4.1 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1948-03-09 Creatinine [Mass/volume] in Serum or Plasma 0.92 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 1948-03-09 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1943)/1.73 sq M 66 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1948-03-09 Glucose [Mass/volume] in Serum or Plasma 102 mg/dL (high)
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1948-03-09 Hemoglobin A1c/Hemoglobin.total in Blood 5.9% (high)
Reference Below 5.7% is normal; 5.7 to 6.4% prediabetes; 6.5% or more diabetes
http://loinc.org · 4548-4
S 1948-03-09 Thyrotropin [Units/volume] in Serum or Plasma 2.2 mIU/L
Reference 0.4-4 mIU/L
http://loinc.org · 3016-3
S 1948-03-09 Natriuretic peptide B [Mass/volume] in Serum or Plasma 48 pg/mL
Reference Below 100 pg/mL makes heart failure unlikely
http://loinc.org · 30934-4
S 1948-03-09 Cholesterol [Mass/volume] in Serum or Plasma 228 mg/dL (high)
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 1948-03-09 Cholesterol in HDL [Mass/volume] in Serum or Plasma 56 mg/dL
Reference 50 mg/dL or more for women
http://loinc.org · 2085-9
S 1948-03-09 Triglyceride [Mass/volume] in Serum or Plasma 140 mg/dL
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 1948-03-09 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 144 mg/dL (high)
Reference <=99 mg/dL
http://loinc.org · 13457-7
S 1948-03-09 Albumin/Creatinine [Mass Ratio] in Urine 18 mg/g
Reference <=30 mg/g
http://loinc.org · 9318-7
S 1948-03-09 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 1948-03-09 Total score [ACT] 13 http://loinc.org · 82668-5
S 1948-06-15 Maximum expiratory gas flow Respiratory system airway by Peak flow meter 205 L/min (low)
Reference 80 percent of her personal best of 340 L/min
http://loinc.org · 19935-6
S 1948-09-21 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 1948-09-21 Total score [Mini-Cog] 5 http://loinc.org · 72233-0
S 1948-09-21 Total score [AUDIT-C] 0 http://loinc.org · 75626-2
S 1948-03-23 FEV1 --pre bronchodilation 1.3 L (low)
Reference Lower limit of normal, GLI Global race-neutral equations; predicted 2.03 L
http://loinc.org · 20157-4
S 1948-03-23 FEV1 --post bronchodilation 1.57 L
Reference Lower limit of normal, GLI Global race-neutral equations; predicted 2.03 L
http://loinc.org · 20155-8
S 1948-03-23 FEV1 measured/predicted 64% (low)
Reference GLI Global race-neutral equations
http://loinc.org · 20152-5
S 1948-03-23 FEV1/FVC 0.64 (low)
Reference >=0.7
http://loinc.org · 19926-5
S 1948-03-23 FEV1/FVC --post bronchodilation 0.72
Reference 0.70 or more after bronchodilator: no persistent airflow obstruction
http://loinc.org · 69970-2
S 1948-03-23 Diffusion capacity.carbon monoxide 17.2 mL/min/mm[Hg]
Reference Lower limit of normal, GLI race-neutral; predicted 18.6
http://loinc.org · 19911-7
S 1948-03-23 Fractional concentration of exhaled nitric oxide 46 [ppb] (high)
Reference Above 50 ppb high; 25 to 50 intermediate (ATS)
http://loinc.org · 96269-6
S 1948-03-23 Left ventricular Ejection fraction 62%
Reference 53-73%
http://loinc.org · 10230-1
S 1948-03-23 IgE [Units/volume] in Serum or Plasma 210 [IU]/mL (high)
Reference <=100 [IU]/mL
http://loinc.org · 19113-0
S 1948-03-23 Total score [ACT] 14 http://loinc.org · 82668-5
S 1948-05-04 Total score [ACT] 18 http://loinc.org · 82668-5
S 1948-05-04 Potassium [Moles/volume] in Serum or Plasma 4.2 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1948-05-04 Creatinine [Mass/volume] in Serum or Plasma 0.94 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 1948-05-04 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1943)/1.73 sq M 64 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1948-05-04 Cholesterol [Mass/volume] in Serum or Plasma 170 mg/dL
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 1948-05-04 Cholesterol in HDL [Mass/volume] in Serum or Plasma 57 mg/dL
Reference 50 mg/dL or more for women
http://loinc.org · 2085-9
S 1948-05-04 Triglyceride [Mass/volume] in Serum or Plasma 126 mg/dL
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 1948-05-04 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 88 mg/dL
Reference <=99 mg/dL
http://loinc.org · 13457-7
S 1948-07-27 Total score [ACT] 22 http://loinc.org · 82668-5
S 1948-07-27 FEV1 --pre bronchodilation 1.72 L
Reference Lower limit of normal, GLI Global race-neutral equations; predicted 2.03 L
http://loinc.org · 20157-4
S 1948-07-27 FEV1 measured/predicted 85%
Reference GLI Global race-neutral equations
http://loinc.org · 20152-5
S 1948-07-27 FEV1/FVC 0.73
Reference >=0.7
http://loinc.org · 19926-5
S 1948-07-27 Fractional concentration of exhaled nitric oxide 21 [ppb]
Reference Above 50 ppb high; 25 to 50 intermediate (ATS)
http://loinc.org · 96269-6
S 1948-07-27 Maximum expiratory gas flow Respiratory system airway by Peak flow meter 330 L/min
Reference 80 percent of her personal best of 340 L/min
http://loinc.org · 19935-6
S 1948-07-27 Hemoglobin [Mass/volume] in Blood 13 g/dL
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1948-07-27 Leukocytes [#/volume] in Blood by Automated count 7.1 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1948-07-27 Eosinophils [#/volume] in Blood by Automated count 0.24 10*3/uL
Reference 0-0.5 10*3/uL
http://loinc.org · 711-2
S 1948-07-27 Platelets [#/volume] in Blood by Automated count 255 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1948-07-27 Potassium [Moles/volume] in Serum or Plasma 4.3 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1948-07-27 Creatinine [Mass/volume] in Serum or Plasma 0.96 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 1948-07-27 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1943)/1.73 sq M 62 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1948-07-27 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7

Synthetic vital signs

DateMeasureResultLOINCGrade
1948-03-09Body height163 cm8302-2S
1948-03-09Body weight88 kg29463-7S
1948-03-09Body mass index (BMI) [Ratio]33.1 kg/m239156-5S
1948-03-09Systolic blood pressure152 mm[Hg]8480-6S
1948-03-09Diastolic blood pressure88 mm[Hg]8462-4S
1948-03-09Heart rate82 /min8867-4S
1948-03-09Respiratory rate20 /min9279-1S
1948-03-09Body temperature36.7 Cel8310-5S
1948-03-09Oxygen saturation in Arterial blood by Pulse oximetry95 %59408-5S
1948-06-15Body height163 cm8302-2S
1948-06-15Body weight87.2 kg29463-7S
1948-06-15Body mass index (BMI) [Ratio]32.8 kg/m239156-5S
1948-06-15Systolic blood pressure138 mm[Hg]8480-6S
1948-06-15Diastolic blood pressure82 mm[Hg]8462-4S
1948-06-15Heart rate98 /min8867-4S
1948-06-15Respiratory rate22 /min9279-1S
1948-06-15Body temperature37.4 Cel8310-5S
1948-06-15Oxygen saturation in Arterial blood by Pulse oximetry94 %59408-5S
1948-09-21Body height163 cm8302-2S
1948-09-21Body weight86 kg29463-7S
1948-09-21Body mass index (BMI) [Ratio]32.4 kg/m239156-5S
1948-09-21Systolic blood pressure126 mm[Hg]8480-6S
1948-09-21Diastolic blood pressure76 mm[Hg]8462-4S
1948-09-21Heart rate70 /min8867-4S
1948-09-21Respiratory rate16 /min9279-1S
1948-09-21Body temperature36.6 Cel8310-5S
1948-09-21Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
1948-03-23Body height163 cm8302-2S
1948-03-23Body weight87.6 kg29463-7S
1948-03-23Body mass index (BMI) [Ratio]33 kg/m239156-5S
1948-03-23Systolic blood pressure146 mm[Hg]8480-6S
1948-03-23Diastolic blood pressure86 mm[Hg]8462-4S
1948-03-23Heart rate78 /min8867-4S
1948-03-23Respiratory rate18 /min9279-1S
1948-03-23Body temperature36.6 Cel8310-5S
1948-03-23Oxygen saturation in Arterial blood by Pulse oximetry96 %59408-5S
1948-05-04Body height163 cm8302-2S
1948-05-04Body weight87 kg29463-7S
1948-05-04Body mass index (BMI) [Ratio]32.7 kg/m239156-5S
1948-05-04Systolic blood pressure134 mm[Hg]8480-6S
1948-05-04Diastolic blood pressure80 mm[Hg]8462-4S
1948-05-04Heart rate76 /min8867-4S
1948-05-04Respiratory rate16 /min9279-1S
1948-05-04Body temperature36.6 Cel8310-5S
1948-05-04Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
1948-07-27Body height163 cm8302-2S
1948-07-27Body weight86.4 kg29463-7S
1948-07-27Body mass index (BMI) [Ratio]32.5 kg/m239156-5S
1948-07-27Systolic blood pressure128 mm[Hg]8480-6S
1948-07-27Diastolic blood pressure78 mm[Hg]8462-4S
1948-07-27Heart rate72 /min8867-4S
1948-07-27Respiratory rate16 /min9279-1S
1948-07-27Body temperature36.5 Cel8310-5S
1948-07-27Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

Care-plan goals

GoalTarget dateStatusOutcome
A confirmed diagnosis within three weeks: spirometry with bronchodilator response, FeNO and an echocardiogram, with the pulmonology consultation1948-03-23completedAsthma confirmed by a 21 percent, 270 mL bronchodilator response and FeNO 46 ppb; heart failure excluded; hypertensive heart disease found, two weeks after the first visit
Asthma Control Test 20 or more, no night waking, and travel to Washington without breathlessness1948-07-27completedAsthma Control Test 22; no night waking; travelled to two board meetings
Correct inhaler technique with her own inhaler at every visit, and a written asthma action plan she can use1948-05-04completedTechnique corrected with a spacer at six weeks; action plan written at diagnosis and used during the exacerbation
Blood pressure below 130/80 at home and in clinic1948-07-27completedClinic 128/78; home average 126/76 on amlodipine
No exacerbation needing oral corticosteroids1948-07-27completedNot achieved: one moderate exacerbation with a cold, treated with five days of prednisone without admission

Interventions

InterventionStatusGuideline
Pulmonology consultation in two weeks with spirometry before and after bronchodilator, DLCO and FeNO, to confirm or refute asthma, separate it from COPD and heart disease, and plan treatmentcompletedGL-GINA-2025, GL-NAEPP-2020, GL-CMID-2026
Work-up of wheeze and breathlessness: chest X-ray, ECG, blood count with eosinophils, BNP, TSH and kidney function today; transthoracic echocardiogram before the consultation; albuterol continued as needed until testing, holding it for six hours before spirometrycompletedGL-GINA-2025, GL-NAEPP-2020, GL-AHA-HF-2022
Home blood pressure readings twice daily for a week, with a validated upper-arm cuff, because clinic readings are raisedcompletedGL-AHA-HTN-2025, GL-CMID-2026
Equity safeguards: spirometry read with race-neutral GLI Global equations, plain explanation of every result, and a check at each visit that her symptoms are not put down to her weight or agecompletedGL-ATS-RACE-2023, GL-MMWR-ASTHMA-2021
GINA track 1: budesonide-formoterol 160/4.5 mcg as maintenance and reliever (one inhalation twice daily and one as needed, no more than 12 a day), albuterol stopped; inhaler technique, adherence and Asthma Control Test at every visit; a written asthma action plan with peak flow zones; review six weeks after any change and within a week of any exacerbationcompletedGL-GINA-2025, GL-NAEPP-2020, GL-CMID-2026
Hypertensive heart disease without heart failure: amlodipine 5 mg daily (a beta-blocker avoided because of asthma), a lower-salt diet, home readings, and kidney function and potassium at follow-upcompletedGL-AHA-HTN-2025, GL-CMID-2026
Cardiovascular prevention: atorvastatin 20 mg daily for a 10-year ASCVD risk above 20 percentcompletedGL-AHA-HTN-2025
Upper airway and reflux: fluticasone nasal spray and saline rinses, ear, nose and throat review with nasal endoscopy; omeprazole for eight weeks for heartburn with meal timing and head-of-bed elevation, then stop if settledcompletedGL-GINA-2025, GL-CMID-2026
Weight and fitness, as she chooses: a dietitian visit, a walking plan she can follow on campus and in Washington, and a later discussion of medicines for weight if she wants onecompletedGL-GINA-2025, GL-CMID-2026
Biologic assessment: not indicated while asthma is controlled on low-to-medium dose ICS-formoterol with good technique; repeat blood eosinophils and refer for biologic therapy if asthma becomes uncontrolled on step 4 to 5 treatment or there are two or more exacerbations needing oral corticosteroids in a yearcompletedGL-GINA-2025, GL-CMID-2026

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Mary McLeod Bethune (The Roosevelts and African American Civil Rights Leaders) National Park Service government
SRC-0002 The Council House National Park Service, Mary McLeod Bethune Council House National Historic Site government
SRC-0003 Mary McLeod Bethune Council House National Historic Site National Park Service government
SRC-0004 Podesta J. Bethune, Mary McLeod 1875-1955 (Contemporary Black Biography) Encyclopedia.com (Gale) biography
SRC-0005 Baxter D. Bethune, Mary McLeod (1875-1955) (Women in World History: A Biographical Encyclopedia) Encyclopedia.com (Gale) biography
SRC-0006 Mary McLeod Bethune Papers: The Bethune Foundation Collection, Part 1 (guide to the microfilm edition) University Publications of America (LexisNexis) primary
SRC-0007 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the separation of asthma from COPD and heart failure (bronchodilator response, post-bronchodilator ratio, DLCO, FeNO, BNP and echocardiogram), the choice of GINA track 1 maintenance-and-reliever therapy and the decision not to step up before technique was corrected, the exacerbation management and the missed in-person review within a week, the biologic assessment, amlodipine rather than a beta-blocker, and the statin decision.
provenance reviewnot_startedShe died in 1955; the recent-death rule does not apply. Claims rest on three National Park Service pages, two reference biographies on Encyclopedia.com, and the University Publications of America guide to her foundation's papers. Her chronic asthma and the 1942 attack are D from one reference biography, corroborated by the archival guide. The sinus surgery at Johns Hopkins could not be verified and is left out. Her heart disease before her fatal heart attack is not documented; the retrospective claim is R, possible.
safe messaging reviewnot_startedNo mental health or substance claim is made; mood screens are synthetic and below the threshold for a safety assessment. Obesity is recorded in her words and with her agreement. Her death is recorded once, without detail. No relative is given a role in the modern episode; the president and the first lady of her Washington years are not named.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.